EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features

Amir Dori iD, Michael Arad, Yishay Wasserstrum, Arthur Pollak, Vera Nikitin, Merav Ben-David, Jana Shamash, Ayelet Hashachar Nahum, Efrat Shavit-Stein, Liran Domachevsky, Rafael Kuperstein, Dan Dominissini und 4 weitere

Annals of Clinical and Translational Neurology · 2023-04 · 10 (4) · 553-567

DOI: 10.1002/acn3.51741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 11.02.2023. Verfasst von Amir Dori und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Cardiomyopathies, Carpal Tunnel Syndrome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Amyloidosis due to the transthyretin Ser77Tyr mutation (ATTRS77Y) is a rare autosomal‐dominant disorder, characterized by carpal‐tunnel syndrome, poly‐ and autonomic‐neuropathy, and cardiomyopathy. However, related symptoms and signs are often nonspecific and confirmatory tests are required. We describe the age and frequency of early symptoms and diagnostic features among individuals of Jewish Yemenite descent in Israel.

Methods

Records of mutation carriers were retrospectively reviewed. ATTRS77Y diagnosis was defined by the presence of amyloid in tissue and/or amyloid‐related cardiomyopathy.

Results

We identified the Ser77Tyr mutation at the heterozygous state in 19 amyloidosis patients (mean age at diagnosis: 62 ± 5.7 years, range 49–70) and 30 amyloid‐negative carriers. The probability for disease diagnosis increased from 4.4% at age 49 to 100% at 70 and occurred earlier in males. Initial symptoms preceded diagnosis by 5 ± 3.8 years (range 0–12) and were commonly sensory changes in the extremities. Erectile dysfunction predated these in 8/13 (62%) males. In two patients cardiac preceded neurological symptoms. Two patients declined symptoms. Electrophysiological studies near the time of diagnosis indicated a median neuropathy at the wrist in 18/19 (95%) and polyneuropathy in 13/19 (68%). Skin biopsy revealed epidermal denervation in 15/16 (94%) patients. Cardiomyopathy was identified in 16/19 (84%). Sensory complaints or epidermal denervations were present in 17/30 (57%) of amyloid‐negative carriers and co‐occurred in 10/30 (33%).

Interpretation

ATTRS77Y symptoms commonly occur after age 50, but may begin earlier. Median neuropathy, skin denervation and cardiomyopathy are frequently identified. Symptoms may be absent in patients and common in amyloid‐negative carriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialCardiomyopathiesCarpal Tunnel SyndromeAgedFemaleHumansMaleMiddle AgedAmyloidIsraelRetrospective StudiesPrealbumin

Substanzen

AmyloidPrealbumin

Autor:innen und Institutionen

  • Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel.
  • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • The Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel.
  • Department of Cardiology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel Hashomer, Israel.
  • Department of Nuclear Medicine, Sheba Medical Center, Tel Hashomer, Israel.

ORCID-Profile: Amir Dori, Lior Greenbaum

Förderung

  • Pfizer

Zitieren

APA

Dori, A., Arad, M., Wasserstrum, Y., Pollak, A., Nikitin, V., Ben-David, M., Shamash, J., Nahum, A. H., Shavit-Stein, E., Domachevsky, L., Kuperstein, R., Dominissini, D., Shelestovich, N., Sadeh, M., Pras, E., & Greenbaum, L. (2023). Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features. Annals of Clinical and Translational Neurology, 10(4), 553-567. https://doi.org/10.1002/acn3.51741

Vancouver

Dori A, Arad M, Wasserstrum Y, Pollak A, Nikitin V, Ben-David M, et al. Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features. Annals of Clinical and Translational Neurology. 2023;10(4):553-567. doi:10.1002/acn3.51741

BibTeX
@article{Dori2023,
  author = {Dori, Amir and Arad, Michael and Wasserstrum, Yishay and Pollak, Arthur and Nikitin, Vera and Ben-David, Merav and Shamash, Jana and Nahum, Ayelet Hashachar and Shavit-Stein, Efrat and Domachevsky, Liran and Kuperstein, Rafael and Dominissini, Dan and Shelestovich, Natalia and Sadeh, Menachem and Pras, Elon and Greenbaum, Lior},
  title = {Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2023},
  volume = {10},
  number = {4},
  pages = {553--567},
  doi = {10.1002/acn3.51741}
}
Kostenlos starten →